Compare · MMM vs NVRO
MMM vs NVRO
Side-by-side comparison of 3M Company (MMM) and Nevro Corp. (NVRO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MMM and NVRO operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM carries a market cap of $100.22B.
- MMM has hit the wire 16 times in the past 4 weeks while NVRO has been quiet.
- Both have 25 recent analyst ratings on file.
- Company
- 3M Company
- Nevro Corp.
- Price
- -
- -
- Market cap
- $100.22B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NYSE
- IPO
- 2014
- News (4w)
- 16
- 0
- Recent ratings
- 25
- 25
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Nevro Corp.
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. In addition, the company provides HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Latest MMM
- The Dow Rallies Back Above a Key Average, but Five Charts Made Even Bigger Moves Today
- 3M Reaches Broad Resolution of AFFF Personal Injury Litigation
- 3M Board Approves New $6 Billion Share Repurchase Authorization, Declares Quarterly Dividend
- Meguiar’s® Reveals Ford F-100 & Aston Martin GT3 in its 2026 SEMA Booth
- EVP Chief Strategy Officer Van Wyck Jonathan G. exercised 1,501 shares at a strike of $174.34 and covered exercise/tax liability with 460 shares, increasing direct ownership by 400% to 1,302 units (SEC Form 4)
- Meguiar’s® Unleashes a Trove of New 2027 Car Care Products: Continuing 125 Years of Innovation!
- 3M and AWS collaborate to advance optical connectivity innovation
- Outside Big Tech, Tuesday's Earnings Winners Jumped as Much as 11%
- SEC Form 10-Q filed by 3M Company
- Money20/20 USA Underway with NYSE as Exchange Partner: NYSE Content Update
Latest NVRO
- SEC Form 15-12G filed by Nevro Corp.
- SEC Form EFFECT filed by Nevro Corp.
- Amendment: SEC Form SCHEDULE 13D/A filed by Nevro Corp.
- Director Mccormick Shawn returned 46,035 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Kosaraju Sridhar returned 46,575 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Grossman D Keith returned 228,552 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SVP, Chief Financial Officer Macleod Roderick H. returned 350,663 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Demane Michael F returned 503,618 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Karros Kirt P returned 17,452 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Oboyle Kevin C returned 43,396 shares to the company, closing all direct ownership in the company (SEC Form 4)